Case Study
Agora
An interactive platform to visually explore curated genomic analyses of Alzheimer's Disease
Allowing researchers to share and explore curated genomic analyses of AD.
The analyses accessible through Agora represent the culmination of over five years of research from the dozens of scientists that are part of the NIH-led Accelerating Medicines Partnership – Alzheimer’s Disease (AMP-AD) Target Discovery and Preclinical Validation Project.
The analyses accessible through Agora represent the culmination of over five years of research from the dozens of scientists that are part of the NIH-led Accelerating Medicines Partnership – Alzheimer’s Disease (AMP-AD) Target Discovery and Preclinical Validation Project.
"It is enabling precision medicine and facilitating the principles of open science and rapid dissemination of new targets with more shots on goal for AD."
Eliezer Masliah, M.D.
Director of the Division of Neuroscience at NIA
Feature 1
Description here. Description here. Description here. Description here. Description here. Description here.
Feature 2
Description here. Description here. Description here. Description here. Description here. Description here.
Feature 3
Description here. Description here. Description here. Description here. Description here. Description here.
Feature 4
Description here. Description here. Description here. Description here. Description here. Description here.
Agora in the News
Data Science
Test Blog
This is a test post. For example, if the literature were more accessible, then science would be more inclusive of the people who otherwise would not be able to read the literature. They could be better informed about potential applications in scholarly work, commercial development, and translation into policy or...
Read more